Suppr超能文献

[具体物质名称]在肝癌中的表达及预后意义。 你提供的原文中“and”前后应该有具体物质名称未完整给出,我按此格式进行了翻译。请补充完整准确信息以便更精准翻译。

Expression and prognostic significance of and in liver cancer.

作者信息

Xie Dafei, Yuan Peiwen, Wang Dong, Jin Hua, Chen Hui

机构信息

Department of General Surgery, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China.

Intensive Care Unit, Zhejiang Hospital, Hangzhou, Zhejiang 310013, P.R. China.

出版信息

Oncol Lett. 2017 Aug;14(2):2305-2309. doi: 10.3892/ol.2017.6423. Epub 2017 Jun 20.

Abstract

The purpose of this study was to investigate the expression of and in liver cancer, and examine the correlations with pathological parameters and prognosis. We collected tumors and tumor-adjacent normal tissue from 70 patients with liver cancer admitted to the Department of General Surgery of Zhejiang Hospital. The expression of by RT-qPCR was significantly lower in liver cancer tissues than that in the tumor-adjacent normal tissues, and the low expression was correlated with the lymphatic metastasis and TNM stage. By contrast, the expression of was significantly higher in liver cancer than that in the tumor-adjacent tissues, and the high expression was correlated with the lymphatic metastasis and TNM stage. The overall 5-year survival rate of patients was 12.9% (9/70). Single-factor survival analysis revealed that and were the factors affecting the overall survival rate of liver cancer (P<0.05) and multivariate survival analysis by Cox proportional hazards model showed that and were the independent factors affecting the survival time of patients with liver cancer. Low expression of and high expression of are closely correlated with the occurrence and development of liver cancer, especially lymphatic metastasis and TNM stage. Thus, and can serve as reference biomarkers for guiding the treatment of liver cancer and for estimating prognosis.

摘要

本研究旨在探讨[具体基因名称1]和[具体基因名称2]在肝癌中的表达情况,并检测其与病理参数及预后的相关性。我们收集了浙江省立同德医院普通外科收治的70例肝癌患者的肿瘤组织及癌旁正常组织。通过RT-qPCR检测发现,[具体基因名称1]在肝癌组织中的表达明显低于癌旁正常组织,且低表达与淋巴转移及TNM分期相关。相反,[具体基因名称2]在肝癌组织中的表达明显高于癌旁组织,且高表达与淋巴转移及TNM分期相关。患者的总体5年生存率为12.9%(9/70)。单因素生存分析显示,[具体基因名称1]和[具体基因名称2]是影响肝癌总体生存率的因素(P<0.05),Cox比例风险模型多因素生存分析表明,[具体基因名称1]和[具体基因名称2]是影响肝癌患者生存时间的独立因素。[具体基因名称1]低表达和[具体基因名称2]高表达与肝癌的发生发展密切相关,尤其是淋巴转移和TNM分期。因此,[具体基因名称1]和[具体基因名称2]可作为指导肝癌治疗及评估预后的参考生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e7/5530117/a95c95caed07/ol-14-02-2305-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验